Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1998-10-28
|
pubmed:abstractText |
Cyclosporine for the treatment of psoriasis constitutes a new approach. Alternative systemic cyclosporine derivatives have been studied to find an immunosuppressive drug with fewer adverse effects. Tacrolimus is one of these new immunosuppressive drugs. Systematically, it has been proven effective in treating psoriasis. A topical formulation of tacrolimus is attractive because it has fewer adverse effects and is useful for a large group of patients. We report for the first time on the efficacy of nonocclusive topical tacrolimus in the treatment of psoriasis.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0003-987X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1101-2
|
pubmed:dateRevised |
2008-3-17
|
pubmed:meshHeading |
pubmed-meshheading:9762021-Administration, Cutaneous,
pubmed-meshheading:9762021-Chronic Disease,
pubmed-meshheading:9762021-Humans,
pubmed-meshheading:9762021-Immunosuppressive Agents,
pubmed-meshheading:9762021-Pilot Projects,
pubmed-meshheading:9762021-Psoriasis,
pubmed-meshheading:9762021-Tacrolimus
|
pubmed:year |
1998
|
pubmed:articleTitle |
Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study.
|
pubmed:affiliation |
Department of Dermatology, Academisch Medisch Centrum, Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|